Silverarc Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
2023
Q4
$843K Buy
2023
Q1
Sell
2022
Q4
$9.22M Buy
2022
Q3
$1.67M Buy
2021
Q2
Sell
2021
Q1
$808K Sell
2020
Q4
$4.62M Buy